Ultralife Corp. (ULBI) Misses Q4 EPS by 10c

Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of ($0.01), $0.10 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $36.1 million versus the consensus estimate of $37 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

You May Also Be Interested In

• Citi turns more bullish on trucking stocks
• ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
• Hyperion DeFi raises FY26 guidance, launches $20M buyback